Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698062 | SCV000732701 | likely benign | not provided | 2020-10-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000864942 | SCV001005830 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000864942 | SCV002799486 | likely benign | Alstrom syndrome | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003155249 | SCV003845043 | likely benign | not specified | 2023-02-20 | criteria provided, single submitter | clinical testing | Variant summary: ALMS1 c.3263C>G/p.Thr1088Arg (also known as c.3269C>G/p.Thr1090Arg in RefSeq) results in a non-conservative amino acid change located in the ALMS repeat (IPR040972) of the encoded protein sequence. Two of three in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 248652 control chromosomes, predominantly at a frequency of 0.0026 within the South Asian subpopulation in the gnomAD database, including 2 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 1.5-fold of the estimated maximal expected allele frequency for a pathogenic variant in ALMS1 causing Alstrom Syndrome With Dilated Cardiomyopathy phenotype (0.0018), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. To our knowledge, no occurrence of c.3263C>G in individuals affected with Alstrom Syndrome With Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. A co-occurrence with a pathogenic variant has been reported via internal testing (MYBPC3 c.2827C>T, p.Arg943X), providing supporting evidence for a benign role. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as likely benign. |